Coaching Tip

AUGUST 31, 2011

For much of our nation’s history, business by and large was America’s heart and soul, focused on the long-term good. Al Weatherhead is the author of The Power of Adversity and chairman and CEO of Weatherchem, a private manufacturer of plastic closures for food, spice, pharmaceutical and nutraceutical products.

Pharmaceuticals 90

Pharmaceuticals Uncertainty Power Long-term 90

The Horizons Tracker

NOVEMBER 29, 2023

According to a study conducted by the Indiana University Kelley School of Business, diversity in terms of gender, race, and ethnicity has proven to be beneficial for companies operating in the United States. “We looked at their experiences and not just their demographic background—the more functional aspect of diversity. ” .”

Diversity 95

Diversity Innovation Biotechnology Short-term 95

Tanveer Naseer

MAY 16, 2011

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. Are You Fitting Employee Personality Into Your Leadership Puzzle?

Bureaucracy 203

Bureaucracy Compliance Learning-by-Doing Engineering 203

Coaching Tip

MARCH 15, 2011

Now I know this may be scant solace to an individual who’s been out of work and looking for a job a long time. Nothing has ever been able to keep it down for long, and nothing ever will, if we are patient and allow our economy the time to heal itself through the virtues of the free-market system. . Deregulation.

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

Harvard Business Review

OCTOBER 6, 2016

Investments in traditional leadership development are often misguided and a waste of money. In a Deloitte study of 7,000 organizations this year, 89% of executives rated “ strengthening the leadership pipeline ” an urgent issue. Paul Garbett for HBR. It’s not that development itself isn’t important.

Leadership Pipeline 12

Leadership Pipeline Leadership After Action Review Pharmaceuticals 12

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. In addition, many top pharma customers (payers, etc.)

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

Harvard Business Review

SEPTEMBER 23, 2014

Take the case of Janssen, the pharmaceuticals arm of Johnson & Johnson, which created a breakthrough innovative program called Immersion. They overcame short-term thinking. A majority of public companies pledge allegiance to short-term profit over long-term vision. But it does happen.

Innovation 11

Innovation P&L Short-term Company 11

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. That, in brief, is the concept of a leadership circle. In short, today’s existing leadership structure, expertise and purpose are designed to address today’s challenges — not tomorrow’s.

Leadership 10

Leadership Diversity Committee Long-term 10

The Recovering Engineer

FEBRUARY 27, 2010

My friend’s brother-in-law was so focused on the symptom (water on the floor) that he didn’t stop long enough to fix the root cause (water flowing through the water heater). You and I might define the problem in different terms. Once the supply of water stopped, the leak slowed and they could clean-up the mess. Maybe we do.

Health Care 102

Health Care Engineering System Politics 102

The Recovering Engineer

FEBRUARY 27, 2010

My friend’s brother-in-law was so focused on the symptom (water on the floor) that he didn’t stop long enough to fix the root cause (water flowing through the water heater). You and I might define the problem in different terms. Once the supply of water stopped, the leak slowed and they could clean-up the mess. Maybe we do.

Health Care 102

Health Care Engineering System Politics 102

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. from that of a fully integrated pharmaceutical company into a company that retained key technical expertise (e.g., Accordingly, I transformed the business model ?

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

DECEMBER 14, 2017

In the CVS-Aetna case, the care provider, a pharmaceutical retailer and pharmaceutical benefit manager, provides a very limited set of health services: drugs, drug purchasing, and selected, basic, routinized primary care at more than 1,100 local Minute Clinics located in communities around the United States.

Health Care 8

Health Care System Insurance Pharmaceuticals 8

Harvard Business Review

JULY 28, 2015

How long will recruiters spend on your résumé before deciding to toss it in the recycle bin? Avoid generic terms such as results-driven , proven track record , excellent communication skills , team player. Avoid generic terms. Six seconds, says online job search site The Ladders. That’s about 20 to 30 words.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

OCTOBER 28, 2011

The story is a familiar one: A company's quarterly earnings fall significantly short of the investment community's expectations, and the CEO announces a restructuring, including a cut in R&D, to lower costs, regardless of the negative impact on the firm's long-term prospects. Not necessarily. Can we influence who our shareholders are?

CEO 10

CEO Short-term Long-term Restructuring 10

Harvard Business Review

JANUARY 26, 2011

environmental, social and governance) metrics relevant to long-term sustainable corporate performance. Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. The exchange has already established listing requirements for responsibility reporting, for example. Stay tuned.

Long-term 14

Long-term Sample Report Pharmaceuticals 14

Harvard Business Review

JANUARY 15, 2016

I teach at Rutgers University in New Jersey, the epicenter for many major companies in pharmaceuticals, insurance, and banking. Floyd and the BPV leadership team realized that to market in today’s digital environment they had to finally move away from both “brochures” and fear of the digital realm. How can this be?

Industry 8

Industry Marketing Company Compliance 8

Harvard Business Review

JANUARY 15, 2017

We also discovered a staggering lack of confidence in leadership: 71% of survey respondents said government officials are not at all or somewhat credible, and 63% said the same about CEOs. In absolute terms the results are troubling for business. Just 52% of respondents to our survey said they trust business to do what is right.

Survey 11

Survey Media Globalization Policies 11

Harvard Business Review

JUNE 22, 2016

For example, do you make and sell things, hire skilled employees and provide services, develop and new IP like software or pharmaceuticals, or build and manage digital networks, be they transactional, informational, or social? Organizational transformation must begin with a leadership transformation.

Intangible Assets 10

Intangible Assets Business Model How To Intellectual Capital 10

Harvard Business Review

APRIL 4, 2018

Or the notorious case of Martin Shkreli, the former CEO of Turing Pharmaceuticals, who failed to apologize for dramatically raising the price of a life-saving drug. ” Creativity is a key criterion for a team’s long-term effectiveness and success. ” and “How useful are those ideas?”

Creativity 13

Creativity Pharmaceuticals Learning-by-Doing Team 13

Harvard Business Review

SEPTEMBER 26, 2011

The stock market is short-term-oriented. Furthermore, these actions are taken seemingly without regard to the consequences for the community, the employees, the survival of the company as an institution, or the creation of long-term firm value. Yes, those actions would have boosted short-term earnings. I disagree.

CEO 15

CEO Short-term Long-term Restructuring 15

Harvard Business Review

MAY 24, 2012

Pharmaceutical manufacturers, insurers, and retailers invest millions in risk avoidance. It takes leadership to establish decision management and closed-loop measurement practices. But through decisive leadership and consistent measurement, plenty of companies have shown it can be done.

Merchandising 10

Merchandising Risk Management Supply Chain Retail 10

Harvard Business Review

JULY 7, 2011

Roger, a vice president of sales and marketing in the pharmaceutical industry, was one such Pleaser. While he longed to advance in his career, Roger had developed a bad habit of avoiding conflict. Years of longing for attention from his loving but preoccupied parents had conditioned him to avoid making waves.

Rogers 14

Rogers Morale Long-term Pharmaceuticals 14

Harvard Business Review

MARCH 16, 2015

. “I would say the biggest challenge that I faced was making sure the organization stayed very focused, thinking about the trends that were shaping the world and what we were going to need to do organizationally to win in the long-term,” said Jim Turley of accounting firm Ernst & Young. Leadership Competition'

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

NOVEMBER 15, 2018

They also do not represent sustainable, long-term change. However, doing this with blanket eliminations of layers carries a risk: inadvertently pruning away the next generation of leadership talent. These actions certainly save money, but typically less than 5% of their total expense base.

Cost 10

Cost System Management Franchising 10

Harvard Business Review

MARCH 24, 2017

Despite having solid internal anti-corruption rules in place, the pharmaceutical giant wound up facing criminal investigations for bribing doctors and foreign officials , eventually paying a $489 million fine. These practices continued under executive leadership that stifled disagreement with superiors and, all told, led to $1.2

Ethics 8

Ethics Company Incentives Policies 8

Harvard Business Review

DECEMBER 27, 2013

In this massive piece, Nicholas Carlson analyzes Armstrong''s rise from his days as the owner of a strawberry business, uncovering a leadership trajectory that culminated in a proxy war with an activist investor and a final realization that his baby — local-news and listings provider Patch — needed to be trimmed, or else. Leadership'

Armstrong 8

Armstrong Long-term Short-term CEO 8

Harvard Business Review

APRIL 22, 2013

Most of us think of biotech as the province of multinational pharmaceutical corporations and well-funded ventures, but the founders of BioCurious believe (as they say in their mission statement) "that innovations in biology should be accessible, affordable, and open to everyone." All you have to bring to the class is interest and curiosity.

Mission Statement 9

Mission Statement Class Learning-by-Doing Pharmaceuticals 9

Harvard Business Review

SEPTEMBER 10, 2013

Indeed, there are people like Hamdi Ulukaya (the Turkish founder of Chobani Greek Yogurt) or the founders of a variety of biotech and pharmaceutical firms who have achieved this through focusing on the purpose of healthier ways for us to eat and live. Entrepreneurship Leadership Organizational culture' Making the world more fun.

Fashion 8

Fashion Real Estate Retail Efficiency 8

Harvard Business Review

OCTOBER 22, 2013

When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. The challenge is finding radical ideas consistently year after year. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

NOVEMBER 1, 2018

HR should be responsible for ensuring, among other things, that leadership has clearly communicated a zero-tolerance position; that employees trust the current procedures; and that reporting mechanisms are easy to understand. Leadership. Human Resources commonly takes the lead in crafting and enforcing a strong policy.

Health Care 8

Health Care Policies How To Reputation 8

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Pharmaceuticals.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

SEPTEMBER 19, 2016

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. In these circumstances, thinking in terms of long-term profit and returns is an important way of putting society’s resources to their best uses. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Harvard Business Review

MARCH 21, 2018

They are then reviewed by the company’s Manufacturing Leadership Council. The term “safety culture” is misleading because it suggests organizations have multiple cultures: one for safety, another for production, and perhaps others for quality and for sales. Use the right incentives. Focus on leading indicators.

Operations 16

Operations Chemicals CEO Metrics 16

Harvard Business Review

MAY 10, 2013

Such a pattern is well established in the pharmaceutical industry as large established firms partner with smaller biotech firms. As Dell''s public statements have pronounced, these changes will reduce near-term profitability, raise operating and capital expenditures and involve a lot of risk. So we are left with a quandary.

Venture Capitalist 8

Venture Capitalist Restructuring Competitive Advantage Short-term 8

Harvard Business Review

APRIL 19, 2016

Those factors do play important roles, but the most important thing driving America’s success has been its unparalleled scientific leadership. In the pharmaceutical industry, the monitoring process can be incredibly elaborate. Lynda Chin , of the University of Texas explains, “Basic science is a long-term proposition.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

MAY 28, 2013

They are realizing it can no longer solely be the charge of HR executives or even of the CEO and top management — and that they must integrate talent management with the long-term strategic goals of the organization if they are to have any hope of claiming competitive advantage. What would this leadership look like over time?

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

MARCH 8, 2011

All too soon, however, the demands of managing the near-term business take over. The surest way to build a company whose leadership will outlast your own is to focus your attention on the few essential things that your company can do better than anyone else. How thoroughly must they transform the company to make this happen?

Merchandising 14

Merchandising Budgeting Pharmaceuticals CEO 14